- Home
- / Bio Preventive Medicine
Bio Preventive Medicine
Stock Price
NT$30.8
2024-10-28
Market Capitalization
NT$1.1 B
2024-10-28
Revenue
NT$12.3 M
FY, 2024
Bio Preventive Medicine Summary
Company Summary
- Overview
- Bio Preventive Medicine is a clinical-staged biotech company. It offers solutions for the prevention, screening, and monitoring of chronic diseases and cancer management.
- Type
- Public
- Status
- Active
- Founded
- 2014
- Website
- https://www.bpmbiotech.com/
- Cybersecurity rating
Table of Contents
Bio Preventive Medicine Financials
Summary Financials
- Revenue (H1, 2025)
- NT$1.0M
- Gross profit (H1, 2025)
- NT$975.0K
- Net income (H1, 2025)
- (NT$49.1M)
- Cash (H1, 2025)
- NT$300.1M
- EBIT (H1, 2025)
- (NT$49.2M)
- Enterprise value
- $995.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026